CIC
LENZ

Cornercap Investment Counsel’s LENZ Therapeutics LENZ Stock Holding History

Cornercap Investment Counsel’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-9,350
Closed -$209K – 707
2024
Q1 		$209K Sell
9,350
-12
-0.1% -$249 0.03% 559
2023
Q4 		$172K Hold
9,362
– – 0.03% 541
2023
Q3 		$163K Sell
9,362
-128
-1% -$2.23K 0.03% 505
2023
Q2 		$173K Hold
9,490
– – 0.03% 525
2023
Q1 		$163K Hold
9,490
– – 0.03% 521
2022
Q4 		$221K Hold
9,490
– – 0.04% 510
2022
Q3 		$211K Buy
+9,490
New +$226K 0.04% 489

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Cornercap Investment Counsel's LENZ Position: Q2 2024 in Review

Cornercap Investment Counsel sold out of LENZ Therapeutics (LENZ) in Q2 2024, closing a stake of 9,350 shares — an estimated $209K sold.

Cornercap Investment Counsel first reported a position in LENZ in Q3 2022 and held it in 7 quarters. The position peaked at $221K in Q4 2022. 65 funds tracked by Wall St. Rank hold LENZ as of Q2 2024.

  • Cornercap Investment Counsel reported no remaining LENZ Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Cornercap Investment Counsel sold 9,350 LENZ Therapeutics shares in Q2 2024, an estimated $209K.
  • Cornercap Investment Counsel first reported a position in LENZ Therapeutics in Q3 2022 and held it in 7 quarters.
  • Cornercap Investment Counsel's LENZ Therapeutics position peaked at $221K in Q4 2022.
  • 65 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2024.

Based on Cornercap Investment Counsel's 13F filing for Q2 2024, filed 8 Aug 2024.